Form 4: RxSight Executive Ilya Goldshleger Executes Stock Option and Sells Shares Under 10b5-1 Plan

Ilya Goldshleger, Co-President and COO of RxSight, Inc., exercised stock options and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On October 25, 2024, Ilya Goldshleger exercised stock options to acquire 3,100 shares of RxSight, Inc. common stock at a price of $15.08 per share.
• Simultaneously, Mr. Goldshleger sold 3,100 shares of common stock at a weighted average price of $49.7937, within a price range of $49.48 to $50.21.
• On October 28, 2024, Mr. Goldshleger again exercised stock options to acquire 3,100 shares at $15.08 per share.
• He then sold another 3,100 shares at a weighted average price of $50.643, within a price range of $50.26 to $51.07.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on June 3, 2024.
• Following these transactions, Mr. Goldshleger directly owns 42,246 shares of common stock and indirectly owns 1,372 shares through his spouse.
• He also holds options to purchase 68,692 shares of common stock.

Sentiment

Score: 5

Explanation: The document reflects routine executive stock transactions under a pre-arranged plan, indicating a neutral sentiment. It doesn't suggest any particular positive or negative outlook for the company.

Industry Context

Executive stock transactions are common and often pre-planned using Rule 10b5-1 plans to avoid insider trading accusations. These transactions can provide insights into an executive's perspective on the company's value, but are often driven by personal financial planning.

Comparison to Industry Standards

• Executive compensation packages in the medical device industry often include stock options as a significant component.
• Rule 10b5-1 trading plans are a standard practice among corporate executives to manage their stock holdings and avoid potential insider trading concerns, similar to practices at companies like Medtronic or Boston Scientific.
• The vesting schedule of the options, with monthly vesting after a commencement date, is a typical arrangement to incentivize long-term commitment.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the change in ownership, but the pre-planned nature of the sales mitigates concerns about insider information.

Key Dates